Efficacy and Safety of tDCS and tACS in Treatment of Major Depressive Disorder: A Randomized, Double-Blind, Factorial Placebo-Controlled Study Design
Yuxin Huang,1 Linjie Shen,1 Jia Huang,1 Xianrong Xu,2 Yong Wang,1 Hua Jin1 1Department of Outpatient, Shanghai Mental Health Center, Shanghai, People’s Republic of China; 2School of Public Health, Hangzhou Normal University, Hnagzhou, Zhejiang Province, People’s Republic of China...
Guardado en:
Autores principales: | Huang Y, Shen L, Huang J, Xu X, Wang Y, Jin H |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/42a2514e2f034e91aa8010e93a6e01bc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Neurostimulation Methods in the Treatment of Depression: A Comparison of rTMS, tDCS, and Venlafaxine Using a Pooled Analysis of Two Studies
por: Hejzlar M, et al.
Publicado: (2021) -
Using Transcranial Electrical Stimulation in Audiological Practice: The Gaps to Be Filled
por: Mujda Nooristani, et al.
Publicado: (2021) -
Online Left-Hemispheric In-Phase Frontoparietal Theta tACS for the Treatment of Negative Symptoms of Schizophrenia
por: Chuan-Chia Chang, et al.
Publicado: (2021) -
A description and critical analysis of the therapeutic uses of transcranial direct current stimulation: implications for clinical practice and research
por: Vance DE, et al.
Publicado: (2016) -
Concurrent conventional & high-definition transcranial direct current stimulation for treatment of schizophrenia with co-morbid obsessive-compulsive disorder: A case report
por: Swarna Buddha Nayok, et al.
Publicado: (2021)